Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation

Abstract

There is clinical evidence linking asthma with the trace element, zinc (Zn). Using a mouse model of allergic inflammation, we have previously shown that labile Zn decreases in inflamed airway epithelium (Truong-Tran AQ, Ruffin RE, Foster PS, Koskinen AM, Coyle P, Philcox JC, Rofe AM, Zalewski PD. Am J Respir Cell Mol Biol 27: 286-296, 2002). Moreover, mild nutritional Zn deficiency worsens lung function. Recently, a number of proteins belonging to the Solute Carrier Family 39 (ZIP) and Solute Carrier Family 30 (ZnT) have been identified that bind Zn and regulate Zn homeostasis. Mice were sensitized, and subsequently aerochallenged, with ovalbumin to induce acute and chronic airway inflammation. Mice received 0, 54, or 100 microg of Zn intraperitoneally. Tissues were analyzed for Zn content and histopathology. Inflammatory cells were counted in bronchoalveolar lavage fluid. Cytokine and Zn transporter mRNA levels were determined by cDNA gene array and/or real-time PCR. Zn supplementation decreased bronchoalveolar lavage fluid eosinophils by 40 and 80%, and lymphocytes by 55 and 66%, in the acute and chronic models, respectively. Alterations in Zn transporter expression were observed during acute inflammation, including increases in ZIP1 and ZIP14 and decreases in ZIP4 and ZnT4. Zn supplementation normalized ZIP1 and ZIP14, but it did not affect mRNA levels of cytokines or their receptors. Our results indicate that inflammation-induced alterations in Zn transporter gene expression are directed toward increasing Zn uptake. Increases in Zn uptake may be needed to counteract the local loss of Zn in the airway and to meet an increased demand for Zn-dependent proteins. The reduction of inflammatory cells by Zn in the airways provides support for Zn supplementation trials in human asthmatic individuals.

The Emerging Role of the LIV-1 Subfamily of Zinc Transporters in Breast Cancer

“…For example, increases in expression of the zinc transporters LIV-1, ZIP12, and ZIP14 have been observed during acute inflammation in the airway and asthma and have been suggested to promote an increase in zinc uptake, which can reduce inflammation (33). The zinc content in brains of individuals with schizophrenia is lower than that of individuals with other cerebral diseases (34), and a role for the ZIP12 gene has been demonstrated by observation of mutations in ZIP12 in a small group of schizophrenic patients.…”

Cortisol stimulates the zinc signaling pathway and expression of metallothioneins and ZnT1 in rainbow trout gill epithelial cells

“…Zinc deficiency has been linked to development of asthma, and zinc supplementation has been shown to reduce the number of inflammatory eosinophil granulocytes and lymphocytes in the bronchoalveolar lavage fluid of mice with induced acute and chronic airway inflammation (32). Lang et al (32) suggested that this reduction in inflammatory cells corresponded to a complex relationship between the expression levels of the zinc transporter, which were directed toward maintaining or increasing intracellular zinc in the lung tissue. Inhaled or orally administered glucocorticoid is the most common treatment for patients with asthma (25).…”

Effectiveness of a pre-procedural mouthwash in reducing bacteria in dental aerosols: randomized clinical trial

“…24 Following this line of thought, zinc has been added to some oral hygiene products due to its good antimicrobial and anti-inflammatory properties 25 and its capacity of neutralizing volatile compounds that play an important role in halitosis. 21,26 Similarly, fluoride has been added to mouthwashes formulations due to its effect in caries prevention 23 and in dental remineralization.…”